(2026). Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden. Ophthalmology and Therapy.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Prospective Real-World Outcomes After Switching to Aflibercept 8 Mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden."
Ophthalmology and Therapy 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Prospective Real-World Outcomes After Switching to Aflibercept 8 Mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden."
Ophthalmology and Therapy, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.